Daniel Zhang

Daniel Zhang

Auto-generated profile, based on publicly available information

Daniel Zhang

Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2022 in Nature
Verified
Journal Article
Closed access
PDF file
YZYi Zhou
Yi Zhou
YSYijing Su
Yijing Su
SLShiying Li
Shiying Li
BKBenjamin C. Kennedy
Benjamin C. Kennedy
DZDaniel Y. Zhang
Daniel Y. Zhang
HSHongjun Song
Hongjun Song

16 January 2025 in Nature
Verified
Journal Article
Closed access
PDF file
YSYusha Sun
Yusha Sun
XWXin Wang
Xin Wang
DZDaniel Y. Zhang
Daniel Y. Zhang
ZZZhijian Zhang
Zhijian Zhang
JBJanardhan P. Bhattarai
Janardhan P. Bhattarai
HSHongjun Song
Hongjun Song

31 January 2018 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
JGJacob M. Goldberg
Jacob M. Goldberg
FWFang Wang
Fang Wang
CSChanan D. Sessler
Chanan D. Sessler
NVNathan W. Vogler
Nathan W. Vogler
DZDaniel Y. Zhang
Daniel Y. Zhang
SLStephen J. Lippard
Stephen J. Lippard

4 April 2025 in Molecular Cancer Research
Verified
Journal Article
Closed access
Martin J BakerMartin J Baker
Martin J Baker
SZSuli Zhang
Suli Zhang
DZDaniel Zhang
Daniel Zhang
JSJoshua Searle
Joshua Searle
PLPriti Lal
Priti Lal
MCMariana Cooke
Mariana Cooke
The small G-protein Rac1 is a central player in cancer progression and metastatic dissemination. Rac1 has been established as a bona fide effector of receptor tyrosine kinases, acting as a signaling node for motility, invasiveness, mitogenesis, and gene expression. Previous studies demonstrated that Rac1 is hyperactivated in aggressive cellular models of prostate cancer. In this study, we demonstrate that CRISPR/Cas9-mediated knockout of Rac1 results in impaired proliferation and migration of prostate cancer cells. Rac1-null cells display profound alterations in transcriptional programs, particularly those associated with cell adhesion and extracellular matrix regulation. Combined expression profiling and unbiased RNAi screening of Rac1 guanine nucleotide exchange factors identified VAV2 as the foremost mediator EGF-induced GTP loading onto Rac1 in prostate cancer cells. Depletion of VAV2 from prostate cancer cells significantly reduced their proliferative and migratory capacities without affecting the expression of Rac1-regulated genes, suggesting that VAV2 controls a discrete subset of Rac1-dependent cellular responses. IHC assessment in human prostate biopsies showed significant VAV2 overexpression in tumor areas. Bioinformatic analysis revealed a strong correlation between VAV2 expression and poor clinical prognosis. In addition to uncovering a prominent role for VAV2–Rac1 as an effector pathway mediating EGFR-driven proliferative and migratory responses in prostate cancer cells, our findings underscore the potential prognostic value of VAV2 in human prostate cancer progression. Implications: This study highlights the central role of VAV2 in prostate cancer cell proliferation and migration, as well as its potential prognostic value in disease progression.

4 August 2025
Verified
Other
Open access
PDF file
Martin J BakerMartin J Baker
Martin J Baker
SZSuli Zhang
Suli Zhang
DZDaniel Zhang
Daniel Zhang
JSJoshua Searle
Joshua Searle
PLPriti Lal
Priti Lal
MCMariana Cooke
Mariana Cooke
Figure S4. Validation of Rac1-regulated genes from the RNA-Seq analysis.

4 August 2025
Verified
Other
Open access
PDF file
Martin J BakerMartin J Baker
Martin J Baker
SZSuli Zhang
Suli Zhang
DZDaniel Zhang
Daniel Zhang
JSJoshua Searle
Joshua Searle
PLPriti Lal
Priti Lal
MCMariana Cooke
Mariana Cooke
Figure S7. Expression of Rac1-regulated genes in VAV2 KO cells.